However, further preclinical studies, especially those focusing on ALD and MetALD models, and prospective clinical trials are necessary to fully translate these promising anticancer benefits to human patients
Many patients experience modest weight rebound (2 to 5 pounds) during a 2 to 4 week medication pause, though individual responses vary
The typical retatrutide titration for GLP-1 naive individuals starts at 1mg weekly
(2024) 47:S179218
Data analysed by one-way ANOVA, multiple comparison, Bonferroni post hoc test ( f , g , j , l - n , r and s ), two-way repeated measures ANOVA to assess main effects of treatment ( b , c , e and k ), and ANCOVA computed with calR using body weight as a covariate ( p )